Wells Trecaso Financial Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,367
Closed -$221K 91
2022
Q4
$221K Sell
2,367
-500
-17% -$48.2K 0.11% 77
2022
Q3
$273K Hold
2,867
0.15% 67
2022
Q2
$266K Sell
2,867
-100
-3% -$9.76K 0.14% 71
2022
Q1
$300K Sell
2,967
-500
-14% -$52.5K 0.13% 72
2021
Q4
$358K Hold
3,467
0.16% 65
2021
Q3
$294K Hold
3,467
0.14% 68
2021
Q2
$289K Buy
3,467
+125
+4% +$10.2K 0.14% 68
2021
Q1
$251K Hold
3,342
0.13% 68
2020
Q4
$228K Buy
+3,342
New +$217K 0.13% 66
2020
Q3
Sell
-3,207
Closed -$208K 72
2020
Q2
$208K Buy
+3,207
New +$202K 0.14% 64

Other funds holding CVS

Wells Trecaso Financial Group's CVS Position: Q1 2023 in Review

Wells Trecaso Financial Group sold out of CVS Health (CVS) in Q1 2023, closing a stake of 2,367 shares — an estimated $221K sold.

Wells Trecaso Financial Group first reported a position in CVS in Q2 2020 and held it in 10 quarters. The position peaked at $358K in Q4 2021. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • Wells Trecaso Financial Group reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
  • Wells Trecaso Financial Group sold 2,367 CVS Health shares in Q1 2023, an estimated $221K.
  • Wells Trecaso Financial Group first reported a position in CVS Health in Q2 2020 and held it in 10 quarters.
  • Wells Trecaso Financial Group's CVS Health position peaked at $358K in Q4 2021.
  • 2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Wells Trecaso Financial Group's 13F filing for Q1 2023, filed 20 Apr 2023.